Skip to main content
OpenTrials
Completed

NCT Number: NCT00831298

Assessment of Sleep Disturbance in Alzheimer Disease

The purpose of this study is to study circadian rhythms, or daily cycles of sleep, wake, and activity. The investigators hope to learn how disturbed sleep in Alzheimer's Disease relates to changes in activity cycles, and how sleep disturbances may affect your daytime alertness.

This project selects patients suffering from memory problems, or voluntary to be in our Control Group. There are three parts to this study: Sleep Diaries, Behavioral Questionnaire, and Activity Recordings

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • alzheimer disease
  • MMSE > 20
  • over 65 years old

Exclusion criteria

  • new psychotropic drug treatment
  • patient unable to do neuropsychologic tests

Treatment and study plan

Analysis of sleep disturbance

Other

Behavioral Questionnaire Sleep Recordings Genetic analysis

Primary outcomes

  1. assessment of apathy

    Time frame: at day 0, just after inclusion

Secondary outcomes

  1. assessment of sleep disturbance

    Time frame: during a week, between day 0 and day 7

  2. determine a genetic relationship between sleep disturbance and alzheimer disease

    Time frame: after all genetic analyses of the study

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Nice

Other

Registry information

Important dates

Study start
2010
Primary completion
2011
Study completion
2011
First posted
Jan 28, 2009
Registry last updated
Mar 31, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.